Bookrunner Jefferies conducts offering; lead manager JMP will assist
By Devika Patel
Knoxville, Tenn., June 14 – Minerva Neurosciences, Inc. said it priced its $50 million public sale of stock with a $7.5 million greenshoe. The offering was announced Monday.
The company will sell 5,263,158 common shares at $9.50 per share. The price per share reflects a 6.31% discount to the June 13 closing share price of $10.14.
Jefferies LLC is the bookrunner.
Settlement is expected June 17.
Proceeds will be used for clinical development, working capital and general corporate purposes.
The clinical-stage biopharmaceutical company is based in Cambridge, Mass.
| Issuer: | Minerva Neurosciences, Inc.
|
| Issue: | Common stock
|
| Amount: | $50 million
|
| Greenshoe: | $7.5 million, or 789,473 shares
|
| Shares: | 5,263,158
|
| Price: | $9.50
|
| Warrants: | No
|
| Bookrunner: | Jefferies LLC
|
| Lead manager: | JMP Securities LLC
|
| Announcement date: | June 13
|
| Pricing date: | June 14
|
| Settlement date: | June 17
|
| Stock symbol: | Nasdaq: NERV
|
| Stock price: | $10.14 at close June 13
|
| Market capitalization: | $270.76 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
